Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report

Elizabeth M. O'brien, Peter B. Rosenquist, James N. Kimball, Gregory N. Dunn, Bryan Smith, Lorraine M. Arias

Research output: Contribution to journalArticle

13 Scopus citations


Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

Original languageEnglish (US)
Pages (from-to)131-133
Number of pages3
JournalJournal of ECT
Issue number2
Publication statusPublished - Jun 1 2010
Externally publishedYes



  • Dexmedetomidine
  • ECT
  • Morbid obesity
  • Postictal agitation
  • Sedation
  • α2 agonist

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Cite this